As of January 22, 2025, Dermapharm (DMP.F) has a market cap of $2.34 billion USD. According to our data, Dermapharm is ranked No.3886 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $2.34 B |
7.55%
|
Dec 30, 2024 | $2.17 B |
-6.24%
|
Dec 29, 2023 | $2.32 B |
14.89%
|
Dec 30, 2022 | $2.02 B |
-55.71%
|
Dec 30, 2021 | $4.56 B |
57.47%
|
Dec 30, 2020 | $2.89 B |
45.47%
|
Dec 30, 2019 | $1.99 B |
83.42%
|
Dec 28, 2018 | $1.08 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
GlaxoSmithKline
GSK
|
$68.38 B |
0.002 M
|
UK
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Teva Pharmaceutical Industries
TEVA
|
$25.08 B |
19.908 M
|
Israel
|
Novo Nordisk
NVO
|
$335.53 B |
64.154 B
|
Denmark
|
Market Cap | = | DMP.F Stock Price | * | DMP.F Shares Outstanding |
= | $42.41 | * | 53.84 M | |
= | $2.34 B |